Determinants of cardiovascular disease and sequential decision-making for treatment among women: A Heckman's approach

Raman Mishra1, Monica1

  • 1International Institute for Population Sciences, Mumbai, India.

SSM - Population Health
|February 16, 2019
PubMed

Insights

Older women, particularly those widowed or divorced with lower socioeconomic status, face higher health risks. Key risk factors include diabetes, hypertension, obesity, and poor diet, influencing treatment-seeking behaviors.

Area of Science:

  • Public Health
  • Epidemiology
  • Sociology

Background:

  • Certain demographics and lifestyle factors are associated with elevated health risks in women.
  • Understanding these associations is crucial for targeted health interventions.

Purpose of the Study:

  • To identify demographic and socioeconomic factors associated with elevated health risks in women.
  • To determine the primary risk factors contributing to these health issues.
  • To analyze the determinants of treatment-seeking behavior among women.

Main Methods:

  • The study likely involved a retrospective analysis of health data.
  • Statistical methods were used to identify risk factors and associations.
  • Factors influencing healthcare access and utilization were examined.

Main Results:

  • Women over 40, from lower socioeconomic backgrounds, and those widowed or divorced exhibit increased health risks.
  • Diabetes, hypertension, obesity, and unhealthy diets are identified as significant risk factors.
  • Conversely, women over 40 in higher socioeconomic groups and married women show higher rates of seeking treatment.

Conclusions:

  • Health risks and treatment-seeking behaviors in women are significantly influenced by age, socioeconomic status, marital status, and lifestyle choices.
  • Autonomy, accessibility, affordability, and availability of healthcare services are critical factors affecting treatment-seeking behavior.

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...